Lake Street Maintains Buy on Apyx Medical, Raises Price Target to $9
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Frank Takkinen maintains a Buy rating on Apyx Medical (NASDAQ:APYX) and raises the price target from $6 to $9.
June 15, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Apyx Medical's price target has been raised from $6 to $9 by Lake Street analyst Frank Takkinen, who maintains a Buy rating on the stock.
The news of Lake Street analyst Frank Takkinen maintaining a Buy rating on Apyx Medical and raising the price target from $6 to $9 is positive for the stock. This indicates that the analyst has a bullish outlook on the company's performance and believes the stock is undervalued at its current price. As a result, this news is likely to have a positive short-term impact on APYX's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100